Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study predated formal guideline requirements and GLP but performed according to existing scientific standards. Reliabilty check by Expert Panel (American Chemistry Council Fatty Nitrogen Derivatives) passed.

Data source

Reference
Reference Type:
review article or handbook
Title:
In vivo mouse micronucleus assay of ditallow dimethyl ammonium chloride (DTDMAC) for mutagenic potential (only abstract available)
Author:
Wong, T.K.; Thompson, E.D.
Year:
1977
Bibliographic source:
P&RS Division. Unpublished report BSBTS # 114

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Deviations:
not specified
GLP compliance:
no
Type of assay:
micronucleus assay

Test material

Constituent 1
Reference substance name:
61783-78-8
IUPAC Name:
61783-78-8
Constituent 2
Reference substance name:
Ditallowalkyldimethylammonium chloride
IUPAC Name:
Ditallowalkyldimethylammonium chloride
Details on test material:
- Name of test material (as cited in study report): Ditallowdimethylammonium chloride (DTDMAC)
- Physical state: liquid
- Analytical purity: 74.1 % active in water / isopropanol
- Impurities (identity and concentrations): no data
- Composition of test material, percentage of components: no data
- Isomers composition: no data
- Purity test date: no data
- Lot/batch No.: no data
- Expiration date of the lot/batch: no data
- Radiochemical purity (if radiolabelling): n.a.
- Specific activity (if radiolabelling): n.a.
- Locations of the label (if radiolabelling): n.a.
- Expiration date of radiochemical substance (if radiolabelling): n.a.
- Stability under test conditions: no data
- Storage condition of test material: no data

Test animals

Species:
mouse
Strain:
other: C3D2F1/J
Sex:
male
Details on test animals or test system and environmental conditions:
no data

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Vehicle(s)/solvent(s) used: physiol. saline
- Justification for choice of solvent/vehicle: recommended vehicle
Details on exposure:
Two doses 24 hours apart; sacrifice 6 and 24 hours after second dose
Duration of treatment / exposure:
two single treatments 24 hours apart
Frequency of treatment:
two single treatments 24 hours apart
Post exposure period:
6 and 24 hours respectively
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
0 mg/kg body weight
Basis:
actual ingested
Remarks:
Doses / Concentrations:
50 mg/kg body weight
Basis:
actual ingested
Remarks:
Doses / Concentrations:
500 mg/kg body weight
Basis:
actual ingested
Remarks:
Doses / Concentrations:
1000 mg/kg body weight
Basis:
actual ingested
No. of animals per sex per dose:
8 male mice per group
Control animals:
yes, concurrent vehicle
Positive control(s):
no data

Examinations

Tissues and cell types examined:
bone marrow cells from both femurs
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION: standard spacing

Evaluation criteria:
1000 polychromatic erythrocytes scored from each mouse and micronuclei recorded
Statistics:
analysis of variance

Results and discussion

Test results
Sex:
male
Genotoxicity:
negative
Toxicity:
not specified
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
not specified
Additional information on results:
Reliability check by ACCFND Expert Panel revealed a reliability with restriction (Klimisch 2A)

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative
Based on the available information, ditallowdimethylammonium chloride (DTDMAC) is considered to be not mutagenic in an in vivo micronucleus test.
Executive summary:

Ditallowdimethylammonium chloride was investigated for potential mutagenic effects in an in vivo micronucleus test. Eight mice per group were used and were dosed twice within 24 hours with 0, 50, 500 or 1000 mg/kg body weight via gavage. Physiological saline was used as the control vehicle. The dosing volume was 0.2 mL per dose group. Six hours after the second dosing, one group at each dose was sacrificed. The remaining groups were sacrificed 24 hours after the second dose. Immediately after sacrifice, bone marrow cells were extracted from both femurs and processed. One thousand polychromatic erythrocytes were scored from each mouse and micronuclei were recorded. There were no statistically significant differences in the mean micronuclei of the test groups compared to the negative control group. Based on the results DTDMAC was considered negative in the in vivo micronucleus test.